Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 35 min ago
Peer-reviewedLicence not statedJAMA Dermatology

End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa

  • Albertine Lynch1
  • Julie Archimbaud1
  • Cécile Lesort1
  • Liza Benzoni1
  • Lucas Klepfisch2
  • Denis Jullien1
  • Philippe Guillem3
  • Axel P. Villani1
  1. 1Dermatology Department, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France
  2. 2Paediatric Nephrology, Rheumatology and Dermatology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France
  3. 3Department of Surgery, Clinique du Val d’Ouest, Ecully, France
Read full textDOICite

Related

  1. Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Male-predominant, perianal-prone hidradenitis suppurativa in China: A cohort study of 614 patients.
    Yanyu Du, Jingwen Zou, Renliang He +1
    JAAD internationalPeer-reviewedCC BYFull text1 citedGeneral medicineEurope PMC
  3. Real-world patient journey and unmet needs of people with hidradenitis suppurativa: Social media research in China.
    John R Ingram, Wen-Yu Wu, Wenbo Bu +4
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Geospatial Associations of Hidradenitis Suppurativa With Structurally Related Airborne Toxins
    Tara McCaffrey, Beita Badiei, Nina Rossa Haddad +8
    JAMA DermatologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.
    Martina L Porter, Maneli Doroudian Tehrani, Nazrin Ashina +7
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{lynch2026endofdose,
  title = {{End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa}},
  author = {Albertine Lynch and Julie Archimbaud and Cécile Lesort and Liza Benzoni and Lucas Klepfisch and Denis Jullien and Philippe Guillem and Axel P. Villani},
  journal = {JAMA Dermatology},
  year = {2026},
  month = nov,
  doi = {10.1001/jamadermatol.2026.4435},
  url = {https://doi.org/10.1001/jamadermatol.2026.4435},
}
RIS
TY  - JOUR
TI  - End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa
AU  - Albertine Lynch
AU  - Julie Archimbaud
AU  - Cécile Lesort
AU  - Liza Benzoni
AU  - Lucas Klepfisch
AU  - Denis Jullien
AU  - Philippe Guillem
AU  - Axel P. Villani
PY  - 2026
DA  - 2026/11/04
JO  - JAMA Dermatology
DO  - 10.1001/jamadermatol.2026.4435
UR  - https://doi.org/10.1001/jamadermatol.2026.4435
SN  - 2168-6068
SN  - 2168-6084
ER  -